Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,024 public trials 710 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

NCT03336528

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Grady Hospital Atlanta, Georgia, United States
  • Emory University Hospital Clinical Research Network Atlanta, Georgia, United States
  • Mount Sinai New York, United States
  • Providence Medical Research Centre Spokane, Washington, United States
View Trial Details
Completed

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

NCT02623998

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • Health Science Centre Winnipeg, Manitoba, Canada
  • McMaster University Hamilton, Ontario, Canada
  • St. Joseph's Hospital London, Ontario, Canada
View Trial Details
Completed

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

NCT01499082

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 840156 Chandler, Arizona, United States
  • Investigational Site Number 840102 Glendale, Arizona, United States
  • Investigational Site Number 840071 Phoenix, Arizona, United States
  • Investigational Site Number 840121 Sun City, Arizona, United States
View all 193 locations
View Trial Details
Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

NCT02787551

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8400064 Birmingham, Alabama, United States
  • Investigational Site Number 8400073 Fountain Hills, Arizona, United States
  • Investigational Site Number 8400047 Phoenix, Arizona, United States
  • Investigational Site Number 8400103 Bakersfield, California, United States
View all 124 locations
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus

NCT02973321

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8400028 Sheffield, Alabama, United States
  • Investigational Site Number 8400002 Huntington Park, California, United States
  • Investigational Site Number 8400024 Los Angeles, California, United States
  • Investigational Site Number 8400001 Los Angeles, California, United States
View all 59 locations
View Trial Details

Related conditions